Reperfusion Therapy for Acute Myocardial Infarction provides a comprehensive review of reperfusion therapy for ST-segment elevation myocardial infarction (STEMI). Professor Eric R. Bates and his international team of contributors will examine current and future reperfusion therapies for STEMI, in conjunction with the latest clinical trials and guidelines, to bring you the most in-depth and thorough review of management strategies for these patients. This source addresses key developments that will reduce logistical barriers, improve times-to-treatment, and ensure that appropriate medications are administered in patient care. Showing the benefits of reperfusion therapy, this source: examines fibrinolytic agents that can be used alone, or in combination with other care regimens, to improve the benefits of reperfusion therapy and reduce the risks of treatment summarizes the use of percutaneous coronary intervention (PCI) across the spectrum of reperfusion therapy helps specialists identify barriers to the early treatment of patients in various practice environments reviews the clinical relevance and implications of recent clinical trials and the integration of these findings into the current practice of acute reperfusion therapy